Latest Articles

Publication Date
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - Yahoo Finance

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer Yahoo Finance

Published: Dec. 10, 2024, 11 a.m.
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - PR Newswire

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer PR Newswire

Published: Dec. 10, 2024, 11 a.m.
IDEAYA Launches Breakthrough Phase 1 Trial: Novel PARG Inhibitor + KEYTRUDA for Endometrial Cancer - StockTitan

IDEAYA Launches Breakthrough Phase 1 Trial: Novel PARG Inhibitor + KEYTRUDA for Endometrial Cancer StockTitan

Published: Dec. 10, 2024, 11 a.m.
Larger Waistline May Not Be Always Bad: Know Ideal Waist Size If You've Diabetes - Medical Daily

Larger Waistline May Not Be Always Bad: Know Ideal Waist Size If You've Diabetes Medical Daily

Published: Dec. 6, 2024, 7:47 a.m.
Grad students pitch impactful ideas to drive real change - Brighter World

Grad students pitch impactful ideas to drive real change Brighter World

Published: Dec. 4, 2024, 5:34 p.m.
IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors - StreetInsider.com

IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors StreetInsider.com

Published: Oct. 29, 2024, 10:11 a.m.
The Ideas Dome: Massive impact of News.com.au’s About Bloody Time campaign - Mediaweek

The Ideas Dome: Massive impact of News.com.au’s About Bloody Time campaign Mediaweek

Published: Oct. 20, 2024, 9:17 p.m.
SMALL CAP IDEA: Ananda punches above its weight with CBD-derived pain treatment - This is Money

SMALL CAP IDEA: Ananda punches above its weight with CBD-derived pain treatment This is Money

Published: July 1, 2024, 7 a.m.
Woman who had no idea she was pregnant reveals harrowing moment she gave birth to still born baby boy on her b - Daily Mail

Woman who had no idea she was pregnant reveals harrowing moment she gave birth to still born baby boy on her b Daily Mail

Published: March 5, 2024, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!